FDA rules address warning labels

Share this content:

The U.S. Food and Drug Administration has issued rules intended to ensure that medication warning labels are clear and concise. The rule states that pharmaceutical and medical device companies must rush out safety updates on products only if there is clear evidence of a risk not yet reviewed by government.



Next Article in Products